Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Phase: Phase 4"
topic_facet:"Recruitment Status: Authorised-recruitment may be ongoing or finished"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+4%22&filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Authorised-recruitment+may+be+ongoing+or+finished%22&lookfor=Dexamethasone+OR+corticosteroid&type=AllFields
PubPharm (116)
1
The Soft Tissue Injection of Corticosteroid and Local Anaesthetic Study : The Soft Tissue Injection of Corticosteroid And Local anaesthetic Study - A Single site, non-inferiority randomised control trial evaluating pain after soft tissue corticosteroid injections with and without local anaesthetic - The SToICAL Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
The Soft Tissue Injection of Corticosteroid and Local Anaesthetic Study : The Soft Tissue Injection of Corticosteroid And Local anaesthetic Study - A Single site, non-inferiority randomised control trial evaluating pain after soft tissue corticosteroid injections with and without local anaesthetic - The SToICAL Study
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Capability of Tofacitinib or Etanercept to accelerate clinical relevant dose reduction of non-steroidal anti-inflammatory drugs and treat-to-target guided minimization of intake of corticosteroids in patients with active Rheumatoid Arthrtis and an inadequate response to previous csDMARD therapy : Capability of Tofacitinib or Etanercept to accelerate clinical relevant tapering of non-steroidal anti-inflammatory drugs and treat-to-target guided de-escalation of corticosteroids in patients with active Rheumatoid Arthrtis and an inadequate response to previous csDMARD therapy - AcceleRAte
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Capability of Tofacitinib or Etanercept to accelerate clinical relevant dose reduction of non-steroidal anti-inflammatory drugs and treat-to-target guided minimization of intake of corticosteroids in patients with active Rheumatoid Arthrtis and an inadequate response to previous csDMARD therapy : Capability of Tofacitinib or Etanercept to accelerate clinical relevant tapering of non-steroidal anti-inflammatory drugs and treat-to-target guided de-escalation of corticosteroids in patients with active Rheumatoid Arthrtis and an inadequate response to previous csDMARD therapy - AcceleRAte
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Corticosteroid medication in treatment of a sudden inflammation of the voice box among vocal professionals : Corticosteroid in treatment of acute laryngitis among vocal professionals
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
A clinical trial comparing of 4 doses of CHF 5993 100/6/12.5 µg pMDI to 4 doses of CHF 1535 200/6 µg pMDI in subjects with asthma. : A 26 WEEK, RANDOMIZED, DOUBLE BLIND, MULTINATIONAL, MULTICENTRE, ACTIVE CONTROLLED, 2-ARM PARALLEL GROUP TRIAL COMPARING CHF 5993 100/6/12.5 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE PLUS GLYCOPYRRONIUM BROMIDE) TO CHF 1535 200/6 µg pMDI (FIXED COMBINATION OF EXTRAFINE FORMULATION OF BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE) IN SUBJECTS WITH ASTHMA UNCONTROLLED ON MEDIUM DOSES OF INHALED CORTICOSTEROIDS IN COMBINATION WITH LONG-ACTING ß2-AGONISTS. - MiSTIC
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Phase: Phase 4
Filter aufheben
Thema: Recruitment Status: Authorised-recruitment may be ongoing or finished
Medienart
116
Aufsätze
116
E-Artikel
116
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
116
610
Phase: Phase 4
Recruitment Status: Authorised-recruitment may ...
116
Study Type: Interventional
22
Medical Condition: ASTHMA UNCONTROLLED ON MEDIU...
4
Medical Condition: Encephalopathy with electric...
2
Medical Condition: ANCA vasculitis;Therapeutic ...
2
Medical Condition: Acute postoperative pain aft...
2
Medical Condition: Acute respiratory distress s...
2
Medical Condition: All the patients from 1year ...
2
Medical Condition: Analization of specific immu...
2
Medical Condition: Asthma MedDRA version: 20.0L...
2
Medical Condition: Benign prostatic hyperplasia...
2
Medical Condition: Bronchiectasis;Therapeutic a...
2
Medical Condition: COVID-19;Therapeutic area: D...
2
Medical Condition: Cataract senilis;Therapeutic...
2
Medical Condition: Chronic Obstructive Pulmonar...
2
Medical Condition: Clinicaltrial on eosinophil-...
2
Medical Condition: Diabetic Macular Edema MedDR...
2
Medical Condition: Encephalopathy with electric...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
74
2020-
42
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
114
Englisch
2
Unbestimmt
Haven't found what you're looking for?
Wird geladen...